2-Bromo-4′-Cyanoacetophenone CAS 20099-89-2 Puritas >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et elit 2-bromo-4′-Cyanoacetophenone (CAS: 20099-89-2) cum qualitate magna.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com
Nomen chemicum | 2-Bromo-4′-Cyanoacetophenone |
Synonyma | 4-(2-Bromoacetyl) benzonitrile;4-Cyanophenacyl Bromide;4-(Bromoacetyl) benzonitrile;4-(2-Bromo-Acetyl)-Benzonitrile;ω-Bromo-4-Cyanoacetophenone;p-Bromoacetylbenzonitrile |
CAS Number | 20099-89-2 |
CATTUS Number | RF2929 |
Stock Status | In Stock, Productio Capacity 20 Tons per Month |
Formulae hypotheticae | C9H6BrNO |
M. Pondus | 224.06 |
Liquescens punctum | 92.0 ad 96.0℃(lit.) |
Ferveret | 342.4±22.0℃ |
Density | 1.56±0.10 g/cm3 |
Solubilitas | Solutum in Methanol |
Aleam Nota | Corrosivum |
Periculum Classis | 6.1 (8);Venenum, Corrosive |
Stipare Group | II |
HS Code* | 29269090 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White ad lux Yellow / Pinkish Crystal |
Puritas / Analysis Methodus | >98.0% (HPLC) |
Liquescens punctum | 92.0 ad 96.0℃ |
Aqua (auctore Karl Fischer) | <0.50% |
Una immunditia 1 | <1.00% |
Unius immunditiae 2 | <0.50% |
Una immunditia 3 | <0.50% |
Totalis immunditias | <2.00% |
1 H NMR Spectrum | Congruunt cum Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical Intermedia;Isavuconazole Impuritas / Intermediate |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
2-Bromo-4′-Cyanoacetophenone, etiam notus ut 4-(2-Bromoacetyl) benzonitrile;4-Cyanophenacyl Bromide, (CAS: 20099-89-2) materia rudis adhibetur ad synthesim organicam et intermedia pharmaceutica, etc. 4).Isavuconazola est nova triazola hodie in iudiciis clinicis III periodo subeunda.Compositum hoc in vitro actuositatis ostendit contra magnum numerum fermentorum magni ponderis et clinicorum, quos possidet Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., Zygomycetes et Cryptococcus spp.Isavuconazola a Basilea Pharmaceutica gignitur et evolvitur et, in communi cum aliis azolis, per synthesin ergosteroli inhibitionis operatur.Isavuconazole est compositio aquae solubilis (solum latum spectrum aquae triazole solutum) cum oralibus et intravenosis formularum et bioavailabilitatis optimae.Longa eius eliminatio media vita ad semel hebdomadae dosing concedit.Medicamentum antifungal est adhibitum ad curationem aspergillosis incursionis et mucormycosis incursionis.